Warning issued over online weight loss medication

Weight loss jabs
Carolina Rudah / iStock / Getty Images Plus via Getty Images

A consultant pharmacist has issued warnings about the risks to patients when obtaining weight loss medications online, at a virtual GP Pharmacy event, yesterday.

Philip Newland-Jones, consultant pharmacist in diabetes and endocrinology, University Hospital Southampton, said that he had ‘a patient hospitalised this week who managed to get prescribed a weight loss medicine from an online pharmacy with a BMI of 21.’

Related Article: Cross-sector group to tackle barriers faced by Black pharmacy students

The BMI healthy weight range is 18.5 to 24.9 and recently NHS England stipulated that integrated care boards must meet the costs of funding access to the weight-loss injections in primary care settings for patients with a BMI of 40 or higher, and four or more weight-related comorbidities.

Mr Newland-Jones added that he was ‘writing to the General Pharmaceutical Council (GPhC) to report a pharmacy for completely inappropriate prescribing online of weight loss medicines. And I will do that every single time I come across it.’

The session, Treatment of Obesity: what pharmacists need to know, covered new weight-loss jabs and pills, the role of GP pharmacists in advising patients and liaising with private providers.

Related Article: SSP for antidepressant medication issued

Mr Newland-Jones advised the delegate pharmacists to read the GhPC guidance on providing services at a distance including on the internet, as this area of service is likely to expand.

‘I think the guidance was very timely and very welcome, given that it's likely that pharmacists will continue to expand in their provision of obesity medicines, both in the NHS and the private sector going forwards. But we need to get this right if we want to make sure it hits properly.’

Related Article: Pharmacies can join cybersecurity pilot scheme

It follows warnings from pharmacy bodies that NHS provision for weight loss jabs ‘unlikely’ to meet demand and concerns from the Chartered Trading Standards Institute (CTSI) about a ‘Wild West situation’ of unregulated cosmetic procedures taking place in pop up’ shops on high streets, in public toilets and hotel rooms.

The GPhC was contacted for comment.

Want news like this straight to your inbox?
Sign up for our bulletins
Have your say

Leave a Reply

Your email address will not be published. Required fields are marked *

Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.